vs 6,490 other HR bills in the 111th — cohort avg 44d
Summary
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
Lobbying filings that explicitly cite this bill (42)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Cited source text, amounts, lobbyists, and targets
H.R. 1616 - Early Treatment for HIV Act, all sections. Provide States the option to expand Medicaid coverage to early inter-
vention, treatment, and healthcare for people living with HIV.
H. R. 179, Community AIDS and Hepatitis Prevention Act, all sections. Will permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis. P.L.s 111-242, 111-290, 111-317, 111-322: Series of Continuing Appropriations Acts, 2011, all Sections. (seeking to ensure ongoing funding for federal HIV/AIDS prevention, treatment and research functions).
H.R. 4899 - Fiscal 2010 war supplemental bill as pertains to budget enforcement resolution. Sought increase of $126 million for AIDS Drug Assistance Program.
H. Res. 1493 - Budget enforcement resolution. Requested increase for FY 2011 Function 550 allocation for health.
S.Rept. 111-238 - Financial Services Appropriations retain current language on allowing Washington D.C. to use federal funds for syringe access programs. Inclusion of $1.4 million for implementation of National HIV/AIDS Strategy.
S.Rept. 111-243 - Labor, Health and Human Services, Education and Related Agencies, support increased funding for NIH, HRSA and CDC including HIV prevention, treatment, education, training and care, and research. Retain current language on allowing use of federal funds for syringe access programs. End funding for abstinence-only program.
H.Rept. 111-564/S.Rept. 111-230 - Transportation, Housing and Urban Development, and Related Agencies. Support increased funding for Housing Opportunities for People with AIDS (HOPWA).
S.611/H.R.1551: The Responsible Education About Life (REAL) Act, all Sections. Support state grants (and evaluation of grants) for family life education programs, including education on abstinence and contraception for the prevention of teenage pregnancy and sexually transmitted infections (STIs), including HIV/AIDS.
H.R.1429: The Stop AIDS in Prison Act, all Sections. Support development of a comprehensive policy to provide HIV testing, treatment, and prevention for inmates within the correctional setting and upon reentry. (Note: passed House Mar. 17th and now received for action in Senate Judiciary Committee).
H.R. 3001: "Ending LGBT Health Disparities Act," all Titles. Specific support for optional Medicaid coverage of low-income HIV-infected individuals and allowing costs incurred by AIDS drug assistance programs in providing prescription drugs count toward the annual out-of-pocket threshold under Medicare part D.
H.R. 1964: "National Black Clergy for the Elimination of HIV/AIDS Act of 2009," all Titles.
H.R. 2137: "Routine HIV Screening Coverage Act of 2009," all Sections.
H.R. 4140: "Increasing Access to Voluntary Screening for HIV/AIDS and STIs Act of 2009," all Titles.
S.3878/H.R. 6283: "Repealing Ineffective and Incomplete Abstinence-Only Program Funding Act," all Sections. (Seeking to strike Title V, Section 510 from the Social Security Act).
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Natl AIDS Policy, Office of Natl Drug Control Policy (NDCP), SENATE
Cited source text, amounts, lobbyists, and targets
Early Treatment for HIV Act (H.R. 1616/S. 833); Responsible Education about Life Act (H.R.1551/S. 611); Ryan White CARE Act Reauthorization; Issues related to HIV and AIDS education and prevention; Funding for and education regarding comprehensive sexual health education; D.C. Appropriations; Ending LGBT Health Disparities Act (H.R. 3001); Health Care and Education Reconciliation Act of 2010 (H.R. 4872); Health Data Collection Improvement Act of 2010 (H.R. 6109).
Client expense: $400,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
Cited source text, amounts, lobbyists, and targets
- CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions.
- H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions. - S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions.
- H.R. 3138/ S. 301, "A bill to amend title XI of the Social Security Act to provide for transparancy in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP.
- Implementation of Health Care Reform Bill: Medicare Wellness Benefit.
- H.R. 6130, "Strengthening Medicare Anti-Fraud Measures Act of 2010", regarding all provisions.
Client expense: $850,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Early Treatment for HIV Act (H.R. 1616/S. 833); Responsible Education about Life Act (H.R.1551/S. 611); Ryan White CARE Act Reauthorization; Issues related to HIV and AIDS education and prevention; Funding for and education regarding comprehensive sexual health education; D.C. Appropriations; Ending LGBT Health Disparities Act (H.R. 3001); Health Care and Education Reconciliation Act of 2010 (H.R. 4872).
Client expense: $360,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Personnel Management (OPM), SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
Cited source text, amounts, lobbyists, and targets
H.R. 1616 - Early Treatment for HIV Act, all sections. Provide States the option to expand Medicaid coverage to early inter-
vention, treatment, and healthcare for people living with HIV.
H. R. 179, Community AIDS and Hepatitis Prevention Act, all sections. Will permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis. H.R. 4899 - Fiscal 2010 war supplemental bill as pertains to budget enforcement resolution. Sought increase of $126 million for AIDS Drug Assistance Program.
H. Res. 1493 - Budget enforcement resolution. Requested increase for FY 2011 Function 550 allocation for health.
S.Rept. 111-238 - Financial Services Appropriations retain current language on allowing Washington D.C. to use federal funds for syringe access programs. Inclusion of $1.4 million for implementation of National HIV/AIDS Strategy.
S.Rept. 111-243 - Labor, Health and Human Services, Education and Related Agencies, support increased funding for NIH, HRSA and CDC including HIV prevention, treatment, education, training and care, and research. Retain current language on allowing use of federal funds for syringe access programs. End funding for abstinence-only program.
H.Rept. 111-564/S.Rept. 111-230 - Transportation, Housing and Urban Development, and Related Agencies. Support increased funding for Housing Opportunities for People with AIDS (HOPWA).
S.611/H.R.1551: The Responsible Education About Life (REAL) Act, all Sections. Support state grants (and evaluation of grants) for family life education programs, including education on abstinence and contraception for the prevention of teenage pregnancy and sexually transmitted infections (STIs), including HIV/AIDS.
H.R.1429: The Stop AIDS in Prison Act, all Sections. Support development of a comprehensive policy to provide HIV testing, treatment, and prevention for inmates within the correctional setting and upon reentry. (Note: passed House Mar. 17th and now received for action in Senate Judiciary Committee).
H.R. 3001: "Ending LGBT Health Disparities Act," all Titles. Specific support for optional Medicaid coverage of low-income HIV-infected individuals and allowing costs incurred by AIDS drug assistance programs in providing prescription drugs count toward the annual out-of-pocket threshold under Medicare part D.
H.R. 1964: "National Black Clergy for the Elimination of HIV/AIDS Act of 2009," all Titles.
H.R. 2137: "Routine HIV Screening Coverage Act of 2009," all Sections.
H.R. 4140: "Increasing Access to Voluntary Screening for HIV/AIDS and STIs Act of 2009," all Titles.
S.3878/H.R. 6283: "Repealing Ineffective and Incomplete Abstinence-Only Program Funding Act," all Sections. (Seeking to strike Title V, Section 510 from the Social Security Act).
H.R.3081: Continuing Appropriations Act, 2011, all Sections.
Cited source text, amounts, lobbyists, and targets
- CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions.
- H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions. - S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions.
- H.R. 3138/ S. 301, "A bill to amend title XI of the Social Security Act to provide for transparancy in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP.
- Implementation of Health Care Reform Bill: Medicare Wellness Benefit.
- H.R. 6130, "Strengthening Medicare Anti-Fraud Measures Act of 2010", regarding all provisions.
Client expense: $2,410,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
- H.R. 1392, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions. - CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions.
- H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions.
- S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions.
- H.R. 3138/ S. 301, "A bill to amend title XI of the Social Security Act to provide for transparancy in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP.
Client expense: $1,150,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Early Treatment for HIV Act (H.R. 1616/S. 833); Responsible Education about Life Act (H.R.1551/S. 611); Ryan White CARE Act Reauthorization; Issues related to HIV and AIDS education and prevention; Funding for and education regarding comprehensive sexual health education; D.C. Appropriations; Ending LGBT Health Disparities Act (H.R. 3001); Health Care and Education Reconciliation Act of 2010 (H.R. 4872).
Client expense: $740,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 1616 - Early Treatment for HIV Act, all sections. Provide States the option to expand Medicaid coverage to early inter-
vention, treatment, and healthcare for people living with HIV.
H. R. 179, Community AIDS and Hepatitis Prevention Act, all sections. Will permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis. H.R. 4899 - Fiscal 2010 war supplemental bill as pertains to budget enforcement resolution. Sought increase of $126 million for AIDS Drug Assistance Program.
H. Res. 1493 - Budget enforcement resolution. Requested increase for FY 2011 Function 550 allocation for health.
No Bill Number - Financial Services Appropriations retain current language on allowing Washington D.C. to use federal funds for syringe access programs.
No Bill Number - Labor, Health and Human Services, Education and Related Agencies, support increased funding for NIH, HRSA and CDC including HIV prevention, treatment, education, training and care, and research. Retain current language on allowing use of federal funds for syringe access programs. End funding for abstinence-only program.
No Bill Number - Transportation, Housing and Urban Development, and Related Agencies. Support increased funding for Housing Opportunities for People with AIDS (HOPWA).
S.611/H.R.1551: The Responsible Education About Life (REAL) Act, all Sections. Support state grants (and evaluation of grants) for family life education programs, including education on abstinence and contraception for the prevention of teenage pregnancy and sexually transmitted infections (STIs), including HIV/AIDS.
H.R.1429: The Stop AIDS in Prison Act, all Sections. Support development of a comprehensive policy to provide HIV testing, treatment, and prevention for inmates within the correctional setting and upon reentry. (Note: passed House Mar. 17th and now received for action in Senate Judiciary Committee).
H.R. 3001: "Ending LGBT Health Disparities Act," all Titles. Specific support for optional Medicaid coverage of low-income HIV-infected individuals and allowing costs incurred by AIDS drug assistance programs in providing prescription drugs count toward the annual out-of-pocket threshold under Medicare part D.
H.R. 1964: "National Black Clergy for the Elimination of HIV/AIDS Act of 2009," all Titles.
H.R. 2137: "Routine HIV Screening Coverage Act of 2009," all Sections.
H.R. 4140: "Increasing Access to Voluntary Screening for HIV/AIDS and STIs Act of 2009," all Titles.
Cited source text, amounts, lobbyists, and targets
- H.R. 1392, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions. - CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions.
- H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions.
- S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions.
- H.R. 3138/ S. 301, "A bill to amend title XI of the Social Security Act to provide for transparancy in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP.
Client expense: $2,110,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Early Treatment for HIV Act (H.R. 1616/S. 833); Responsible Education about Life Act (H.R.1551/S. 611); Ryan White CARE Act Reauthorization; Issues related to HIV and AIDS education and prevention; Funding for and education regarding comprehensive sexual health education; D.C. Appropriations.
Client expense: $330,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 1616 - Early Treatment for HIV Act, all sections. Provide States the option to expand Medicaid coverage to early inter-
vention, treatment, and healthcare for people living with HIV.
H. R. 179, Community AIDS and Hepatitis Prevention Act, all sections. Will permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis. S.611/H.R.1551: The Responsible Education About Life (REAL) Act, all Sections. Support state grants (and evaluation of grants) for family life education programs, including education on abstinence and contraception for the prevention of teenage pregnancy and sexually transmitted infections (STIs), including HIV/AIDS.
H.R.1429: The Stop AIDS in Prison Act, all Sections. Support development of a comprehensive policy to provide HIV testing, treatment, and prevention for inmates within the correctional setting and upon reentry. (Note: passed House Mar. 17th and now received for action in Senate Judiciary Committee).
H.R. 3590: "Patient Protection and Affordable Care Act," all Titles. Supported inclusion of Early Treatment for HIV Act, allowing States to cover True Out of Pocket (TrOOP) costs under Medicare Part D with AIDS Drug Assistance Program funds, ending health care disparities, public option, Medicaid expansion, data collection provisions, along with prevention, wellness and public health provisions in health care plans.
H.R.4872: Health Care and Education Reconciliation Act of 2010, all Titles. Specific support for improving premium subsidies for the purchase of health insurance for individuals, eliminating lifetime and annual limits on benefits for all health insurance plans, expanding eligibility for Medicaid to all people with income below 133% of FPL, and eliminating the gap in coverage (the doughnut hole) under the Medicare Part D prescription drug program by 2020.
H.R.3962 "Affordable Health Care for America Act." (Original House version of health care reform bill).
H.R. 3001: "Ending LGBT Health Disparities Act," all Titles. Specific support for optional Medicaid coverage of low-income HIV-infected individuals and allowing costs incurred by AIDS drug assistance programs in providing prescription drugs count toward the annual out-of-pocket threshold under Medicare part D.
H.R. 1964: "National Black Clergy for the Elimination of HIV/AIDS Act of 2009," all Titles.
H.R. 2137: "Routine HIV Screening Coverage Act of 2009," all Sections.
H.R. 4140: "Increasing Access to Voluntary Screening for HIV/AIDS and STIs Act of 2009," all Titles.
Cited source text, amounts, lobbyists, and targets
NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D.
H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations.
H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D.
H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills.
S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs.
H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.
Client expense: $860,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 1616 - Early Treatment for HIV Act, all sections. Provide States the option to expand Medicaid coverage to early inter-
vention, treatment, and healthcare for people living with HIV.
H. R. 179, Community AIDS and Hepatitis Prevention Act, all sections. Will permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis. S.611/H.R.1551: The Responsible Education About Life (REAL) Act, all Sections. Support state grants (and evaluation of grants) for family life education programs, including education on abstinence and contraception for the prevention of teenage pregnancy and sexually transmitted infections (STIs), including HIV/AIDS.
H.R.1429: The Stop AIDS in Prison Act, all Sections. Support development of a comprehensive policy to provide HIV testing, treatment, and prevention for inmates within the correctional setting and upon reentry. (Note: passed House Mar. 17th and now received for action in Senate Judiciary Committee).
S.1793/H.R.3792: Ryan White HIV/AIDS Treatment Extension Act of 2009, all Titles. Support four year reauthorization of payer of last resort funding for cities, states, direct clinical services, direct family services, dental, Minority AIDS Initiative (MAI) to provide funding for people living with HIV plus education and training for professionals providing services. Signed into law Oct. 30.
H.R.2996: Interior and Environmet FY 2010 spending bill. Includes continuing appropriations resolution until Dec. 18th. Signed into law Oct. 30, 2009.
H.R.3288: Appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for FY 2010. The conference report on the bill includes provisions for six of the seven FY2010 appropriations: Transportation-HUD; Commerce-Justice-Science; Financial Services; Labor-HHS; Military Construction-VA; and State-Foreign Operations. Specifically, the "minibus" bill includes: H.R.3293 (no bill number in Senate) - Labor, Health and Human Services, Education and Related Agencies, Title II. Support increased funding for NIH, HRSA, SAMHSA and CDC including HIV prevention, treatment, education, training and care, and research. Seek removal of ban on spending federal funds for syringe access. End funding for abstinence-only program. H.R.3288 (no bill number in Senate) - Transportation, Housing and Urban Development, and Related Agencies, Title II. Support increased funding for Housing Opportunities for People with AIDS (HOPWA). S.1432/H.R.3170 - Financial Services Appropriations. Support $1.4 million to the White House Office of National AIDS Policy for the development of a National AIDS Strategy. Seek and/or maintain removal of ban on spending federal and local funds for syringe access for Washington D.C. Signed into law Dec. 16, 2009.
H.R. 3590: "Patient Protection and Affordable Care Act" (Senate version of health care reform bill)/H.R.3962 "Affordable Health Care for America Act." (House version of health care reform bill). Support inclusion of Early Treatment for HIV Act, allowing States to cover True Out of Pocket (TrOOP) costs under Medicare Part D with AIDS Drug Assistance Program funds, ending health care disparities, public option, Medicaid expansion, data collection provisions, along with prevention, wellness and public health provisions in health care plans.
H.R. 3001: "Ending LGBT Health Disparities Act," all Titles. Specific support for optional Medicaid coverage of low-income HIV-infected individuals and allowing costs incurred by AIDS drug assistance programs in providing prescription drugs count toward the annual out-of-pocket threshold under Medicare part D.
H.R. 1964: "National Black Clergy for the Elimination of HIV/AIDS Act of 2009," all Titles.
H.R. 2137: "Routine HIV Screening Coverage Act of 2009," all Sections.
H.R. 4140: "Increasing Access to Voluntary Screening for HIV/AIDS and STIs Act of 2009," all Titles.
Cited source text, amounts, lobbyists, and targets
Early Treatment for HIV Act (HR 1616); Responsible Education about Life Act (S 611, HR 1551); Ryan White CARE Act Reauthorization; Issues related to HIV and AIDS education and prevention; Funding for and education regarding comprehensive sexual health education; D.C. Appropriations.
Client expense: $290,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 1616 - Early Treatment for HIV Act, all sections. Provide States the option to expand Medicaid coverage to early inter-
vention, treatment, and healthcare for people living with HIV.
H. R. 179, Community AIDS and Hepatitis Prevention Act, all sections. Will permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis. S.611/H.R.1551: The Responsible Education About Life (REAL) Act, all Sections. Support state grants (and evaluation of grants) for family life education programs, including education on abstinence and contraception for the prevention of teenage pregnancy and sexually transmitted infections (STIs), including HIV/AIDS.
H.R.1429: The Stop AIDS in Prison Act, all Sections. Support development of a comprehensive policy to provide HIV testing, treatment, and prevention for inmates within the correctional setting and upon reentry. (Note: passed House Mar. 17th and now received for action in Senate Judiciary Committee).
S.1793/H.R.3792: Ryan White HIV/AIDS Treatment Extension Act of 2009, all Titles. Support four year reauthorization of payer of last resort funding for cities, states, direct clinical services, direct family services, dental, Minority AIDS Initiative (MAI) to provide funding for people living with HIV plus education and training for professionals providing services. Signed into law Oct. 30.
H.R.2996: Interior and Environmet FY 2010 spending bill. Includes continuing appropriations resolution until Dec. 18th. Signed into law Oct. 30, 2009.
H.R.3288: Appropriations for the Departments of Transportation, and Housing and Urban Development, and related agencies for FY 2010. The conference report on the bill includes provisions for six of the seven FY2010 appropriations: Transportation-HUD; Commerce-Justice-Science; Financial Services; Labor-HHS; Military Construction-VA; and State-Foreign Operations. Specifically, the "minibus" bill includes: H.R.3293 (no bill number in Senate) - Labor, Health and Human Services, Education and Related Agencies, Title II. Support increased funding for NIH, HRSA, SAMHSA and CDC including HIV prevention, treatment, education, training and care, and research. Seek removal of ban on spending federal funds for syringe access. End funding for abstinence-only program. H.R.3288 (no bill number in Senate) - Transportation, Housing and Urban Development, and Related Agencies, Title II. Support increased funding for Housing Opportunities for People with AIDS (HOPWA). S.1432/H.R.3170 - Financial Services Appropriations. Support $1.4 million to the White House Office of National AIDS Policy for the development of a National AIDS Strategy. Seek and/or maintain removal of ban on spending federal and local funds for syringe access for Washington D.C. Signed into law Dec. 16, 2009.
H.R. 3590: "Patient Protection and Affordable Care Act" (Senate version of health care reform bill)/H.R.3962 "Affordable Health Care for America Act." (House version of health care reform bill). Support inclusion of Early Treatment for HIV Act, allowing States to cover True Out of Pocket (TrOOP) costs under Medicare Part D with AIDS Drug Assistance Program funds, ending health care disparities, public option, Medicaid expansion, data collection provisions, along with prevention, wellness and public health provisions in health care plans.
H.R. 3001: "Ending LGBT Health Disparities Act," all Titles. Specific support for optional Medicaid coverage of low-income HIV-infected individuals and allowing costs incurred by AIDS drug assistance programs in providing prescription drugs count toward the annual out-of-pocket threshold under Medicare part D.
H.R. 1964: "National Black Clergy for the Elimination of HIV/AIDS Act of 2009," all Titles.
H.R. 2137: "Routine HIV Screening Coverage Act of 2009," all Sections.
H.R. 4140: "Increasing Access to Voluntary Screening for HIV/AIDS and STIs Act of 2009," all Titles.
Cited source text, amounts, lobbyists, and targets
- H.R. 1392, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions. - CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions.
- H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions.
- S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions.
- H.R. 3138/ S. 301, "A bill to amend title XI of the Social Security Act to provide for transparancy in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP.
Client expense: $1,640,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
- H.R. 1392, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions. - CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions.
- H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions.
- S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions.
- H.R. 3138/ S. 301, "A bill to amend title XI of the Social Security Act to provide for transparancy in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP.
Client expense: Not reported · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D.
H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations.
H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D.
H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills.
S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs.
H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.
Client expense: $853,020 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Early Treatment for HIV Act (HR 1616); Responsible Education about Life Act (S 611, HR 1551); Ryan White CARE Act Reauthorization; Issues related to HIV and AIDS education and prevention; Funding for and education regarding comprehensive sexual health education; D.C. Appropriations.
Client expense: $250,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
- H.R. 1392, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions. - CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions.
- H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions.
- S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions.
Client expense: $1,660,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D.
H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations
H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills.
H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D.
H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills.
S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs.
NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D.
H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.
Client expense: $952,580 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 1616 - Early Treatment for HIV Act, all sections. Provide States the option to expand Medicaid coverage to early inter-
vention, treatment, and healthcare for people living with HIV.
H. R. 179, Community AIDS and Hepatitis Prevention Act, all sections. Will permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis. S.611/H.R.1551, The Responsible Education About Life (REAL) Act, all sections Support state grants (and evaluation of grants) for family life education programs, including education on abstinence and contraception for the prevention of teenage pregnancy and sexually transmitted infections (STIs), including HIV/AIDS.
H.R.1429, The Stop AIDS in Prison Act, all sections. Support development of a comprehensive policy to provide HIV testing, treatment, and prevention for inmates within the correctional setting and upon reentry. (note: passed House 3/17 and now received for action in Senate Judiciary Committee).
S.1294/H.R.2918 - Continuing Appropriations Resolution 2010, continued appropriations for HIV/AIDS prevention, education and training, treatment, care and research programs. In Title II Division B Sec. 139 continuance of Ryan White CARE Act through the period of the continuing appropriations (Oct. 31, 2009).
S.1793/H.R.3792 - Ryan White HIV/AIDS Treatment Extension Act of 2009, all Titles, reauthorization expected before Oct. 31, 2009. Support four year reauthorization of payer of last resort funding for cities, states, direct clinical services, direct family services, dental, Minority AIDS Initiative (MAI) to provide funding for people living with HIV plus education and training for professionals providing services.
H.R.3293 (no bill number in Senate) - Labor, Health and Human Services, Education and Related Agencies, Title II. Support increased funding for NIH, HRSA, SAMHSA and CDC including HIV prevention, treatment, education, training and care, and research. Seek removal of ban on spending federal funds for syringe access. End funding for abstinence-only program .
S.1432/H.R.3170 - Financial Services Appropriations. Support $1.4 million to the White House Office of National AIDS Policy for the development of a National AIDS Strategy. Seek and/or maintain removal of ban on spending federal and local funds for syringe access for Washington D.C.
H.R.3288 (no bill number in Senate) - Transportation, Housing and Urban Development, and Related Agencies, Title II. Support increased funding for Housing Opportunities for People with AIDS (HOPWA).
S.1679/S.1796/H.R.3200 - Health Care Reform legislation (House and Senate). Support inclusion of Early Treatment for HIV Act, allowing States to cover True Out of Pocket (TrOOP) costs under Medicare Part D with AIDS Drug Assistance Program funds, ending health care disparities, public option, Medicaid expansion, data collection provisions, along with prevention, wellness and public health provisions in health care plans.
Cited source text, amounts, lobbyists, and targets
The Early Treatment for HIV Act (HR 1616/S 833) - general support for legislation
Helping Fill the Medicare Prescription Gap Act (HR 2777/S1201) - general support for legislation
Ending the Medicare Disability Waiting Period Act of 2009 (HR 1708/S 700) - general support for legislation
Client expense: $5,757 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
H.R. 1616 - Early Treatment for HIV Act, all sections. Provide States the option to expand Medicaid coverage to early inter-
vention, treatment, and healthcare for people living with HIV.
H. R. 179, Community AIDS and Hepatitis Prevention Act, all sections. Will permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis. H.R. 1551, The Responsible Education About Life (REAL) Act, all sections Support state grants (and evaluation of grants) for family life education programs, including education on abstinence and contraception for the prevention of teenage pregnancy and sexually transmitted infections (STIs), including HIV/AIDS.
H.R. 1429, The Stop AIDS in Prison Act, all sections. Support development of a comprehensive policy to provide HIV testing, treatment, and prevention for inmates within the correctional setting and upon reentry. (note: passed House 3/17 and now received for action in Senate Judiciary Committee).
H.CON.RES.24, Expressing the sense of Congress on the need for a national AIDS strategy.
No Bill Number - Ryan White CARE Act Reauthorization, all Titles, reauthorization expected before Sept. 30, 2009. Support reauthorization of payer of last resort funding for cities, states, direct clinical services, direct family services, dental, Minority AIDS Initiative (MAI) to provide funding for people living with HIV plus education and training for professionals providing services.
No Bill Number - Labor, Health and Human Services, Education and Related Agencies, Title II. Support increased funding for NIH, HRSA, SAMHSA and CDC including HIV prevention, treatment, education, training and care, and research. Seek removal of ban spending federal funds on syringe access. End funding for abstinence-only program .
No Bill Number - Financial Services Appropriations. Support $1.4 million to the White House Office of National AIDS Policy for the development of a National AIDS Strategy.
No Bill Number - Transportation, Housing and Urban Development, and Related Agencies, Title II. Support increased funding for Housing Opportunities for People with AIDS (HOPWA).
No Bill Number - Health Care Reform legislation (House and Senate). Support inclusion of Early Treatment for HIV Act, allowing States to cover True Out of Pocket (TrOOP) costs for HIV with AIDS Drug Assistance Program funds, ending health care disparities, public option in health care plans.
Cited source text, amounts, lobbyists, and targets
Early Treatment for HIV Act (HR 1616); Responsible Education about Life Act (S 611, HR 1551); Ryan White CARE Act Reauthorization; Issues related to HIV and AIDS education and prevention; Funding for and education regarding comprehensive sexual health education; D.C. Appropriations.
Client expense: $330,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 1548 Pathway for Biosimilars Act
S. 1695 Biologics Price Competition and Innovation Act of 2007
Health Care Reform H.R. 1616 Early Treatment for HIV Act of 2009
H.R.1346/S.540 Medical Device Safety Act of 2009
Topics related to the safety of medical products
Creating a federal program to strengthen awareness, education and treatment of chronic kidney disease
H.R.759 Food and Drug Administration Globalization Act of 2009
S.882 Drug and Device Accountability Act of 2009
S.1213/H.R.2502 Patient-Centered Outcomes Research Act of 2009
S. 525, Pharmaceutical Market Access and Drug Safety Act of 2009
Client expense: $700,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Ending the Medicare Disability Waiting Period Act of 2009 (HR 1708/S 700) - general support for legislation.
The Early Treatment for HIV Act (HR 1616/S 833) - general support for legislation.
Helping Fill the Medicare Prescription Gap Act (HR 2777/S 1201) - general support for legislation.
Client expense: $14,109 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
- H.R. 1392, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions. - CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions.
- H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions.
- S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
- H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions.
Client expense: $1,555,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied members of Congress in support of early treatment of HIV/AIDS.
H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D.
H.R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act.Lobbied for passage of the bill.
H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills.
S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs.
S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.
Client expense: $809,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 1616 - Early Treatment for HIV Act, all sections, provide States the option to expand Medicaid coverage to early inter-
vention, treatment, and healthcare for people living with HIV.
H. R. 179, Community AIDS and Hepatitis Prevention Act, all sections, will permit the use of Federal funds for syringe exchange programs for purposes of reducing the transmission of bloodborne pathogens, including HIV and viral hepatitis. H.R. 1551, The Responsible Education About Life (REAL) Act, all sections, support state grants (and evaluation of grants) for family life education programs, including education on abstinence and contraception for the prevention of teenage pregnancy and sexually transmitted infections (STIs), including HIV/AIDS.
H.R. 1429, The Stop AIDS in Prison Act, all sections, support development of a comprehensive policy to provide HIV testing, treatment, and prevention for inmates within the correctional setting and upon reentry.
H.CON.RES.24, Expressing the sense of Congress on the need for a national AIDS strategy.
No Bill Number - Ryan White CARE Act Reauthorization, all Titles, reauthorization expected before Sept. 30, 2009, support reauthorization of payer of last resort funding for cities, states, direct clinical services, direct family services, dental, Minority AIDS Initiative (MAI) to provide funding for people living with HIV plus education and training for professionals providing services.
No Bill Number - Labor, Health and Human Services, Education and Related Agencies, Title II, support increased funding for NIH, HRSA and CDC including HIV prevention, treatment, education, training and care, and research. Seek removal of ban spending federal funds on syringe access. End funding for abstinence-only program .
No Bill Number - support $1.4 million to the White House Office of National AIDS Policy for the development of a National AIDS Strategy.
No Bill Number - Title II, Transportation, Housing and Urban Development, and Related Agencies, Support increased funding for Housing Opportunities for People with AIDS (HOPWA).
Cited source text, amounts, lobbyists, and targets
The Early Treatment for HIV Act (HR 1616/ S 833) - general support
Health Care Reform - general support, ensuring needs of people living with HIV/AIDS are included in reform proposals
Ryan White HIV/AIDS Treatment Modernization Act - implementation and upcoming extension of the legislation
Client expense: $12,679 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Early Treatment for HIV Act (HR 1616); Responsible Education about Life Act (S 611, HR 1551); Ryan White CARE Act Reauthorization; Issues related to HIV and AIDS education and prevention; Funding for and education regarding comprehensive sexual health education; D.C. Appropriations.
Client expense: $360,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 1548 Pathway for Biosimilars Act
S. 1695 Biologics Price Competition and Innovation Act of 2007
Health Care Reform H.R. 1616 Early Treatment for HIV Act of 2009
H.R.1346/S.540 Medical Device Safety Act of 2009
Topics related to the safety of medical products
H.R.759 Food and Drug Administration Globalization Act of 2009
Proposals impacting clinical research
Client expense: $1,260,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Natl AIDS Policy, Office of Natl Drug Control Policy (NDCP), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Personnel Management (OPM), Office of Special Counsel, SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Natl AIDS Policy, Office of Natl Drug Control Policy (NDCP), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Personnel Management (OPM), Office of Special Counsel, SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Natl AIDS Policy, Office of Natl Drug Control Policy (NDCP), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Natl AIDS Policy, Office of Natl Drug Control Policy (NDCP), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Personnel Management (OPM), Office of Special Counsel, SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Natl AIDS Policy, Office of Natl Drug Control Policy (NDCP), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Personnel Management (OPM), Office of Special Counsel, SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Natl AIDS Policy, Office of Natl Drug Control Policy (NDCP), SENATE
Client expense: $15,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Personnel Management (OPM), Office of Special Counsel, SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Office of Special Counsel, SENATE, State, Dept of (DOS), Treasury, Dept of, White House Office
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)